Pregabalin as a Treatment for Seizures or Neuropathic Pain

Course overview

Pregabalin is a drug that has Food and Drug Administration (FDA) approval for the treatment of neuropathic pain, including pain that is associated with spinal cord injury and diabetic peripheral neuropathy (DPN). It also has received FDA approval for fibromyalgia and postherpetic neuralgia. For patients with epilepsy, pregabalin is approved as an adjunctive treatment for partial-onset seizures in patients 1 month of age and older. This course provides insights into the various indications, potential adverse effects, and dosing in individuals suffering from diverse nervous system maladies that result in the prescribing of pregabalin.